CIK: 1220024 - Address: C/o Optimer Pharmaceuticals, Inc., 101 Hudson Street, Jersey City, NJ 07302
40 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/3/10 19:13
3/1/10
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSVP,HRM.d48330.4201649119D
3/3/10 19:13
3/1/10
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSVP,HRS.d-87655.200-16-4519D
7/24/08 13:31
7/22/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuM.d4823.8502319D
7/24/08 13:31
7/22/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuS.d-10050.000-2-199D
11/29/07 15:19
11/29/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuM.d26638.01073D
11/29/07 15:19
11/29/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuS.d-31545.000-7-683D
10/29/07 13:40
10/26/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuM.d16528.62063D
10/29/07 13:40
10/26/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOSr.VP BuS.d-24041.540-6-643D
4/19/05 16:38
4/15/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
4/19/05 16:38
4/15/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-2350.0000-980D
3/3/05 16:12
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
3/3/05 16:12
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-2553.9800-980D
2/3/05 15:02
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d2626.43010D
2/3/05 15:02
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-6565.120-1-990D
1/5/05 16:52
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d11829.66040D
1/5/05 16:52
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-29373.970-4-1000D
12/21/04 14:47
12/17/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1630.74010D
12/21/04 14:47
12/17/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-3668.200-1-980D
12/3/04 16:22
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d121.55000D
12/3/04 16:22
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-348.3200-860D
11/2/04 19:47
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d2626.43010D
11/2/04 19:47
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-6464.340-1-1000D
10/18/04 14:55
10/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1630.74010D
10/18/04 14:55
10/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-3463.620-1-1000D
10/5/04 14:25
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
10/5/04 14:25
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-2961.0900-1000D
9/2/04 16:53
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
9/2/04 16:53
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-2859.1500-1000D
8/4/04 16:38
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
8/4/04 16:38
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-2758.1700-1000D
7/2/04 16:04
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d14829.88050D
7/2/04 16:04
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-34769.880-5-1000D
6/3/04 17:26
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
6/3/04 17:26
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-3881.2700-1000D
5/5/04 17:14
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1021.55000D
5/5/04 17:14
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-3473.3800-1000D
4/27/04 16:46
4/26/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. M.d1,93047.690400D
4/27/04 16:46
4/26/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP Bus. S.d-3,28481.160-40-1000D
3/5/04 11:43
3/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP HR,AdM.d9121.55040D
3/5/04 11:43
3/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAmper Linda ENYOVP HR,AdS.d-18143.000-4-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact